Second Sight Medical Products, Inc. (EYES) Financial Statements (2023 and Earlier)
Company Profile
| Business Address |
13170 TELFAIR AVE. SYLMAR, CA 91342 |
| State of Incorp. | CA |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 70 | 3 | 11 | 4 | 8 | 11 | 16 | ||
| Cash and cash equivalents | 70 | 3 | 11 | 4 | 8 | 11 | 0 | ||
| Short-term investments | 16 | ||||||||
| Receivables | 0 | 1 | 2 | 0 | 2 | ||||
| Inventory, net of allowances, customer advances and progress billings | 1 | 3 | 3 | 3 | 8 | ||||
| Inventory | 1 | 3 | 3 | 3 | 8 | ||||
| Other undisclosed current assets | 1 | 1 | 0 | 1 | 1 | 1 | 1 | ||
| Total current assets: | 71 | 4 | 13 | 10 | 13 | 15 | 27 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 0 | 2 | ✕ | ✕ | ✕ | ✕ | |||
| Property, plant and equipment | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||
| Deposits noncurrent assets | 0 | ||||||||
| Other undisclosed noncurrent assets | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Total noncurrent assets: | 0 | 0 | 3 | 1 | 1 | 2 | 1 | ||
| TOTAL ASSETS: | 71 | 4 | 17 | 11 | 14 | 17 | 28 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 2 | 2 | 6 | 6 | 6 | 5 | 3 | ||
| Accounts payable | 1 | 0 | 1 | 1 | 1 | 1 | 1 | ||
| Accrued liabilities | 1 | 1 | 2 | 3 | 2 | 2 | 2 | ||
| Employee-related liabilities | 1 | 0 | 3 | 3 | 3 | 2 | |||
| Deferred revenue | 0 | 0 | ✕ | ✕ | ✕ | ✕ | |||
| Debt | 2 | 0 | |||||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 0 | 0 | 0 | ||
| Contract with customer, liability | ✕ | ✕ | ✕ | 0 | ✕ | ✕ | ✕ | ||
| Other undisclosed current liabilities | 1 | 1 | 1 | 1 | 1 | 1 | 5 | ||
| Total current liabilities: | 2 | 5 | 7 | 8 | 7 | 6 | 8 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 0 | 2 | |||||||
| Operating lease, liability | 0 | 2 | ✕ | ✕ | ✕ | ✕ | |||
| Other undisclosed noncurrent liabilities | (0) | ||||||||
| Total noncurrent liabilities: | 0 | 2 | |||||||
| Total liabilities: | 3 | 5 | 9 | 8 | 7 | 6 | 8 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | 68 | (1) | 7 | 3 | 8 | 11 | 20 | ||
| Common stock | 348 | 270 | 264 | 229 | 202 | 187 | 166 | ||
| Additional paid in capital | 49 | 49 | 49 | 44 | 41 | 31 | 27 | ||
| Accumulated other comprehensive loss | (0) | (0) | (1) | (1) | (1) | (1) | (1) | ||
| Accumulated deficit | (329) | (320) | (305) | (269) | (234) | (206) | (173) | ||
| Receivable from shareholders or affiliates for issuance of capital stock | (0) | ||||||||
| Warrants and rights outstanding | 1,038 | ||||||||
| Other undisclosed stockholders' equity attributable to parent | 0 | (1,038) | 0 | ||||||
| Total stockholders' equity: | 68 | (1) | 7 | 3 | 8 | 11 | 20 | ||
| TOTAL LIABILITIES AND EQUITY: | 71 | 4 | 17 | 11 | 14 | 17 | 28 | ||
Income Statement (P&L) ($ in millions)
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 0 | 0 | 3 | 7 | 8 | 4 | 9 | |
| Revenue, net | ✕ | ✕ | ✕ | ✕ | 8 | 4 | ||
| Net investment income | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Cost of revenue | (0) | (1) | (2) | (5) | (5) | (10) | (5) | |
| Cost of goods and services sold | (0) | (1) | (2) | (5) | (5) | (10) | (0) | |
| Other undisclosed gross profit | 0 | 1 | (0) | |||||
| Gross profit: | 0 | 1 | 1 | 2 | 3 | (6) | 4 | |
| Operating expenses | (9) | (15) | (35) | (37) | (31) | (27) | (24) | |
| Operating loss: | (9) | (15) | (34) | (35) | (29) | (33) | (20) | |
| Nonoperating income (Other Nonoperating income) | 0 | |||||||
| Net loss: | (9) | (15) | (34) | (35) | (29) | (33) | (20) | |
| Other undisclosed net income attributable to parent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net loss available to common stockholders, diluted: | (9) | (15) | (34) | (35) | (29) | (33) | (20) | |
Comprehensive Income ($ in millions)
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (9) | (15) | (34) | (35) | (29) | (33) | (20) | |
| Other comprehensive loss | (33) | (20) | ||||||
| Comprehensive loss: | (9) | (15) | (34) | (35) | (29) | (66) | (40) | |
| Other undisclosed comprehensive income, net of tax, attributable to parent | 0 | 0 | 0 | 0 | 0 | 33 | 20 | |
| Comprehensive loss, net of tax, attributable to parent: | (9) | (15) | (34) | (35) | (28) | (33) | (20) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.